New model explains neural basis of alternating bilateral sensory stimulation for fear disorders March 19, 2019
resTORbio announces plans for phase III program with RTB-101 for respiratory tract infections March 18, 2019
Phase IIb study of lebrikizumab in moderate to severe atopic dermatitis meets primary endpoint March 18, 2019
Allergy Therapeutics' phase III trial of adjuvanted birch allergoid product misses primary endpoint March 18, 2019
ReNeuron advances phase I/II retinitis pigmentosa trial of hRPC cell therapy candidate March 18, 2019
New phase II trial assesses TLC-590 for postsurgical pain management following bunionectomy March 18, 2019
RSS